Gastrointestinal malignancies constitute a leading contributor to global cancer-related mortality,with an annually increasing incidence rate.
More therapy techniques are urgently needed to improve clinical efficacy and patient quality of life.
In the therapeutic treatment of digestive tract malignancies, Banxia Xiexin Decoction (BXD), a traditional Chinese medicine prescription, offers benefits such enhancing postoperative and post-chemotherapy unpleasant reactions, decreasing postoperative recurrence and enhancing the synergistic effect of combined chemotherapy medications.
It is still unknown, though, if BXD is beneficial in the treatment of cancers of the digestive tract.
